AngioDynamics Inc. (NASDAQ: ANGO) Thursday reported a net loss for the first quarter of 2025. The medical device company's revenues decreased by
AngioDynamics Inc.
-(ANGO)
XNAS:ANGO
ANGO Earnings: Highlights of AngioDynamics’ Q3 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) has reported a wider net loss for the third quarter of 2024 when the medical device maker's revenue
ANGO Earnings: A snapshot of AngioDynamics’ Q2 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024 when its
Infographic: AngioDynamics reports adjusted loss for Q1 2024; sales down 4%
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the first quarter of 2024 when its
Angiodynamics Inc (ANGO) Q4 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2023 earnings call dated Jul. 12, 2023 Corporate Participants: Jim Clemmer -- Chief Executive Officer Steve Trowbridge -- Chief Financial Officer
Earnings: AngioDynamics (ANGO) reports higher adj. profit for Q4; revenue up 5%
Medical device company AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported an increase in adjusted profit for the fourth quarter of 2023, aided
AngioDynamics Inc. (ANGO) Q3 2023 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by
Why AngioDynamics (ANGO) deserves a place on investors’ watchlist
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large scale during
ANGO Earnings: AngioDynamics Q1 loss widens. Revenue up 6%
AngioDynamics Inc. (NASDAQ: ANGO) on Friday reported a wider loss for the first quarter of 2023, despite a modest increase in revenues.
Angiodynamics Inc (ANGO) Q1 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q1 2023 earnings call dated Oct. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Angiodynamics Inc (ANGO) Q4 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2022 earnings call dated Jul. 12, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates
AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last year. Revenues
ANGO Stock: Is it the right time to invest in AngioDynamics now?
The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing industry. But
AngioDynamics Inc (ANGO) Q3 2022 Earnings Call Transcript
AngioDynamics Inc (NASDAQ:ANGO) Q3 2022 Earnings Call dated Apr. 07, 2022. Coporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A. Trowbridge -- Executive
AngioDynamics (ANGO) Q3 earnings beat estimates as sales increase
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's net sales
Angiodynamics Inc (ANGO) Q2 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q2 2022 earnings call dated Jan. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer
Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q1 2022 earnings call dated Sep. 30, 2021. Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Angiodynamics Inc (ANGO) Q4 2021 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2021 earnings call dated Jul. 13, 2021 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Earnings calendar for the week of July 12
Technology stocks took a beating from the government’s decision to restore net neutrality and weighed on the benchmark indexes mid-week. But, the
AngioDynamics Inc (ANGO) Q3 2021 Earnings Call
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice